The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot clinical study of VAL-413 (oral irinotecan HCl) in patients with recurrent pediatric solid tumors.
 
Dennis Brown
Leadership - Edison Oncology; Kintara Therapeutics; Rakovina Therapeutics
Stock and Other Ownership Interests - stock
 
Jeffrey A. Bacha
Employment - Edison Oncology; Rakovina Therapeutics
Leadership - Edison Oncology; Rakovina Therapeutics; Sernova Corp.
Stock and Other Ownership Interests - Edison Oncology Holding; Kintara Therapeutics; Rakovina Therapeutics
Patents, Royalties, Other Intellectual Property - patents
 
James I. Geller
No Relationships to Disclose
 
Patrick A. Thompson
No Relationships to Disclose
 
Javier E. Oesterheld
Consulting or Advisory Role - Ymabs Therapeutics Inc
Speakers' Bureau - SERVIER
 
Sarath Kanekal
Consulting or Advisory Role - Apollomics; Edison Oncology; Kintara Therapeutics
 
Markos Leggas
No Relationships to Disclose
 
Lorena Lopez
Consulting or Advisory Role - Edison Oncology; Kintara Therapeutics
 
Neil Sankar
No Relationships to Disclose
 
Noymi Yam
Employment - Orbus Therapeutics
Consulting or Advisory Role - Edison Oncology
 
Lars M. Wagner
No Relationships to Disclose